Pfizer standalone net profit declines 39.62% in the March 2026 quarter

Sales rise 6.31% to Rs 629.23 crore

Net profit of Pfizer declined 39.62% to Rs 199.82 crore in the quarter ended March 2026 as against Rs 330.94 crore during the previous quarter ended March 2025. Sales rose 6.31% to Rs 629.23 crore in the quarter ended March 2026 as against Rs 591.91 crore during the previous quarter ended March 2025.

For the full year,net profit declined 5.88% to Rs 722.43 crore in the year ended March 2026 as against Rs 767.60 crore during the previous year ended March 2025. Sales rose 10.45% to Rs 2519.65 crore in the year ended March 2026 as against Rs 2281.35 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	629.23	591.91	6	2519.65	2281.35	10
OPM %	37.50	38.43	-	35.88	32.45	-
PBDT	274.56	269.39	2	1082.56	904.07	20
PBT	259.78	252.99	3	1024.83	843.28	22
NP	199.82	330.94	-40	722.43	767.60	-6

Powered by Capital Market - Live News